Xenon Pharmaceuticals (XENE) News Today → Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed! (From Priority Gold) (Ad) Free XENE Stock Alerts $40.62 +1.12 (+2.84%) (As of 02:32 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineJennison Associates LLC Buys 352,573 Shares of Xenon Pharmaceuticals Inc. (NASDAQ:XENE)marketbeat.com - April 25 at 7:27 AMFederated Hermes Inc. Invests $15.96 Million in Xenon Pharmaceuticals Inc. (NASDAQ:XENE)marketbeat.com - April 23 at 5:35 AMInvestors Purchase High Volume of Put Options on Xenon Pharmaceuticals (NASDAQ:XENE)americanbankingnews.com - April 18 at 3:04 AMXenon Pharmaceuticals Showcases XEN1101 at the American Academy of Neurology 2024 Annual Meetingglobenewswire.com - April 16 at 8:30 AMXenon Pharmaceuticals Inc. (NASDAQ:XENE) Given Consensus Rating of "Buy" by Analystsamericanbankingnews.com - April 16 at 2:34 AMNeedham & Company LLC Reiterates Buy Rating for Xenon Pharmaceuticals (NASDAQ:XENE)marketbeat.com - April 12 at 8:14 AMXenon Pharmaceuticals Inc (XENE)investing.com - April 10 at 12:10 PMXenon Pharmaceuticals to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conferenceglobenewswire.com - April 10 at 8:30 AMXenon Pharmaceuticals to Present at the 23rd Annual Needham Virtual Healthcare Conferenceglobenewswire.com - April 4 at 4:01 PMSG Americas Securities LLC Sells 38,146 Shares of Xenon Pharmaceuticals Inc. (NASDAQ:XENE)marketbeat.com - April 2 at 4:18 AMAssenagon Asset Management S.A. Sells 47,962 Shares of Xenon Pharmaceuticals Inc. (NASDAQ:XENE)marketbeat.com - April 1 at 4:43 AMXenon Pharmaceuticals Incmoney.usnews.com - March 21 at 10:13 AMXenon Pharmaceuticals (NASDAQ:XENE) Is In A Good Position To Deliver On Growth Plansfinance.yahoo.com - March 19 at 8:26 AMXenon Pharmaceuticals Inc. (NASDAQ:XENE) Shares Purchased by Wellington Management Group LLPmarketbeat.com - March 19 at 4:55 AMXENE Apr 2024 47.500 putfinance.yahoo.com - March 16 at 1:48 PMXenon Pharmaceuticals Inc. (NASDAQ:XENE) Position Boosted by Walleye Capital LLCmarketbeat.com - March 15 at 5:21 AMXenon Pharmaceuticals to Present at Stifel 2024 Virtual CNS Daysglobenewswire.com - March 12 at 4:01 PMXenon Pharmaceuticals Inc. (NASDAQ:XENE) Shares Purchased by Qube Research & Technologies Ltdmarketbeat.com - March 12 at 4:35 AMTimesSquare Capital Management LLC Has $20.17 Million Stock Holdings in Xenon Pharmaceuticals Inc. (NASDAQ:XENE)marketbeat.com - March 11 at 9:49 AMInsider Selling: Xenon Pharmaceuticals Inc. (NASDAQ:XENE) EVP Sells 7,137 Shares of Stockinsidertrades.com - March 11 at 6:41 AMInsider Sell: EVP, Strategy & Innovation Sherrington Robin Sells 7,137 Shares of Xenon ...finance.yahoo.com - March 9 at 12:06 AMXenon Pharmaceuticals Inc. (NASDAQ:XENE) EVP Sells $330,300.36 in Stockmarketbeat.com - March 8 at 7:33 PMAdage Capital Partners GP L.L.C. Sells 120,000 Shares of Xenon Pharmaceuticals Inc. (NASDAQ:XENE)marketbeat.com - March 8 at 7:19 AMCantor Fitzgerald Weighs in on Xenon Pharmaceuticals Inc.'s FY2024 Earnings (NASDAQ:XENE)marketbeat.com - March 7 at 7:23 AMXenon Pharmaceuticals to Present at Leerink Partners Global Biopharma Conference 2024globenewswire.com - March 5 at 4:01 PMBuy Rating Affirmed for Xenon Pharmaceuticals on Strong Neurological Pipeline Progressmarkets.businessinsider.com - March 5 at 10:33 AMXenon Pharmaceuticals Inc. (XENE) Q4 2023 Earnings Call Transcriptseekingalpha.com - March 2 at 2:52 PMXenon Pharmaceuticals Inc. (NASDAQ:XENE) Q4 2023 Earnings Call Transcriptfinance.yahoo.com - March 2 at 9:52 AMXenon Pharmaceuticals (NASDAQ:XENE) Posts Quarterly Earnings Results, Beats Estimates By $0.12 EPSmarketbeat.com - March 1 at 2:38 PMXenon Pharmaceuticals Inc.: Xenon Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Updatefinanznachrichten.de - March 1 at 2:30 PMRoyal Bank of Canada Cuts Xenon Pharmaceuticals (NASDAQ:XENE) Price Target to $55.00marketbeat.com - March 1 at 11:21 AMBraidwell LP Has $71.85 Million Position in Xenon Pharmaceuticals Inc. (NASDAQ:XENE)marketbeat.com - March 1 at 10:17 AMXenon Pharmaceuticals (NASDAQ:XENE) Sets New 1-Year High Following Earnings Beatmarketbeat.com - March 1 at 10:14 AMBuy Rating Justified by Xenon Pharmaceuticals’ Advanced Epilepsy Program and Growth Prospects in Neurosciencemarkets.businessinsider.com - March 1 at 9:23 AMXenon Pharmaceuticals (NASDAQ:XENE) Price Target Raised to $51.00marketbeat.com - March 1 at 9:16 AMXenon Pharmaceuticals Inc (XENE) Reports Full Year and Q4 2023 Financial Resultsfinance.yahoo.com - February 29 at 7:35 PMXenon Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Updateglobenewswire.com - February 29 at 4:01 PMFmr LLC Reduces Stake in Xenon Pharmaceuticals Inc. (NASDAQ:XENE)marketbeat.com - February 25 at 5:48 AMXenon Pharmaceuticals (XENE) Scheduled to Post Earnings on Thursdaymarketbeat.com - February 23 at 9:50 AMAlgert Global LLC Has $4.39 Million Stock Holdings in Xenon Pharmaceuticals Inc. (NASDAQ:XENE)marketbeat.com - February 23 at 9:42 AMXenon Pharmaceuticals Announces Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2023 Financial Results and Provide Corporate Updateglobenewswire.com - February 22 at 4:01 PMRathbones Group PLC Makes New Investment in Xenon Pharmaceuticals Inc. (NASDAQ:XENE)marketbeat.com - February 22 at 7:55 AM3 Biotech Stocks That Could Be Multibaggers in the Making: February Editioninvestorplace.com - February 21 at 10:08 PMSilverarc Capital Management LLC Reduces Stake in Xenon Pharmaceuticals Inc. (NASDAQ:XENE)marketbeat.com - February 18 at 12:54 PMLoomis Sayles & Co. L P Sells 22,810 Shares of Xenon Pharmaceuticals Inc. (NASDAQ:XENE)marketbeat.com - February 16 at 7:59 AMFiera Capital Corp Has $19.15 Million Position in Xenon Pharmaceuticals Inc. (NASDAQ:XENE)marketbeat.com - February 14 at 8:52 AMXenon Pharmaceuticals: Analysts Still Positive Despite Recent Trial 'Setbacks'seekingalpha.com - February 8 at 4:30 PMXenon Pharmaceuticals (NASDAQ:XENE) Sets New 1-Year High at $48.00marketbeat.com - February 7 at 2:33 PMIs Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Trading At A 39% Discount?finance.yahoo.com - February 7 at 8:42 AMXenon Pharmaceuticals Inc. (NASDAQ:XENE) Receives Consensus Rating of "Buy" from Brokeragesmarketbeat.com - February 1 at 1:24 AM Get Xenon Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for XENE and its competitors with MarketBeat's FREE daily newsletter. Email Address World’s biggest multibillionaire investor is buying THIS by the ton [picture] (Ad)Don't Buy Bullion or Mining Stocks. Do THIS Instead As gold continues to break all-time highs, many folks will run out and buy bullion or mining stocks. That's not the best way to ride this gold bull market higher. Note, this showed a 995% gain the last time we shared this same investment idea. Click here to find out what to do. XENE Media Mentions By Week XENE Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. XENE News Sentiment▼1.300.42▲Average Medical News Sentiment XENE News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. XENE Articles This Week▼23▲XENE Articles Average Week Get Xenon Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for XENE and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Amicus Therapeutics News IDEAYA Biosciences News Bausch Health Companies News Axsome Therapeutics News Arrowhead Pharmaceuticals News HUTCHMED News Prestige Consumer Healthcare News ACADIA Pharmaceuticals News MoonLake Immunotherapeutics News Ultragenyx Pharmaceutical News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:XENE) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarThe A.I. story nobody is telling you (Read ASAP)TradeSmithRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldHe Is Giving Away BitcoinCrypto Swap Profitstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyYour Money is Not SafeAmerican Alternative Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Xenon Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
